New hair loss cream shows promise in large trial
NCT ID NCT05910450
First seen Jan 09, 2026 · Last updated Apr 22, 2026 · Updated 8 times
Summary
This study tests a topical solution called clascoterone for male pattern baldness. About 700 men with mild to moderate hair loss will apply the drug or a placebo twice daily for 6 months, then responders continue for another 6 months. The goal is to see if it safely increases hair count and improves self-assessed hair coverage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALOPECIA, ANDROGENETIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aversi Clinic
Tbilisi, 0160, Georgia
-
David Abuladze Georgian-Italian Clinic
Tbilisi, 0179, Georgia
-
DelRicht Research
Baton Rouge, Louisiana, 70809, United States
-
DelRicht Research
New Orleans, Louisiana, 70115, United States
-
DelRicht Research
Frisco, Texas, 75034, United States
-
Derm Research Center of New York, Inc.
Stony Brook, New York, 11790, United States
-
DermResearch
Austin, Texas, 78759, United States
-
Diane S. Berson MD, PLLC
New York, New York, 10022, United States
-
Hassman Research Institute
Berlin, New Jersey, 08009, United States
-
Henry Ford Health
Detroit, Michigan, 48202, United States
-
JDR Dermatology Research
Las Vegas, Nevada, 89148, United States
-
JSC Curatio
Tbilisi, 0114, Georgia
-
Kanveni National Center of Dermatology and Venerology
Tbilisi, 0159, Georgia
-
LTD "Medinvestment"
Tbilisi, 0186, Georgia
-
LTD Health
Batumi, 6000, Georgia
-
Mayo Clinic, Department of Dermatology
Jacksonville, Florida, 32224, United States
-
Medi Club
Tbilisi, 0160, Georgia
-
On Site Clinical Solutions
Charlotte, North Carolina, 28277, United States
-
Progressive Clinical Research
San Antonio, Texas, 78213, United States
-
Tbilisi Cancer Center
Tbilisi, 0159, Georgia
-
The Petrus Center for Aesthetic Surgery and Hair Transplantation
North Little Rock, Arkansas, 72116, United States
-
Therapeutics Clinical Research
San Diego, California, 92123, United States
-
University of Miami
Miami, Florida, 33125, United States
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States
Conditions
Explore the condition pages connected to this study.